drugset / Trial / NCT04268927

Extended Letrozole Regimen Co-treatment With Gonadotropin Releasing Hormone Antagonist Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in Poor Responders Undergoing IVF-ET

NCT04268927

Phase 2 Unknown 106 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The object of this study is to evaluate the efficacy of extended letrozole co-treatment with GnRH-antagonist protocol in ovarian stimulation of poor responder patients undergoing IVF-ET.

Timeline

Start
2018-04-01
Primary completion
2020-03-20
Completion
2020-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 2.5 mg
Comparator Bravelle Unknown 300 iu
Comparator Cetrorelix Other / unclassified 0.25 mg Subcutaneous

Indications